MAX vs SRPT · P/E 36, rev $864.7M vs rev $1.90B
MediaAlpha Inc. (MAX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
MediaAlpha Inc. (MAX) is a internet content & information company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MAX revenue for 2024-12-31 was $864.7M. Net income was $22.1M. Revenue was up 122.8% from 2023-12-31 to 2024-12-31. MAX currently screens at market cap $689.0M and trailing P/E 36.2.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
MAX currently screens at market cap $689.0M and trailing P/E 36.2. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MAX and SRPT stock pages for the full models.
Not investment advice.